Linezolid was introduced by the World Health Organization (WHO) in 2022, as part of the BPaLM regimen, also comprising ...

The newly published results of two small clinical trials suggest that two novel antibiotics could provide safer alternatives ...

Current treatment for bedaquiline-resistant tuberculosis is linked with poor microbiological responses, unfavorable clinical ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

The TB death rate in Dharmapuri went down from 12.5% to 7.8%, in Karur from 7.1% to 5.3%, and in Villupuram from 6.1% to 5.2% ...

Tamil Nadu integrates predictive model to reduce TB deaths, prioritizing severely ill patients for prompt hospital admission.